Speaker Profile
Ph.D., Chief Science Officer, Astrin Biosciences
Biography
Dr. Justin Drake is Chief Science Officer at Astrin Biosciences, which has just launched the first blood-based early breast cancer detection test. He is an Associate Professor in the Department of Pharmacology and Urology, a Prostate Cancer Foundation Young Investigator and a Masonic Scholar. He received his B.S. degree from Minnesota State University, Mankato in Biochemistry and Ph.D. degree from the University of Iowa in the Department of Molecular Physiology and Biophysics. Prior to joining the University of Minnesota in 2018, Dr. Drake held a faculty position at the Rutgers Cancer Institute of New Jersey in the Department of Medicine.
Talk
The Emergence of Deep Proteomics for Early Cancer Detection
Advances in nanotechnology and machine learning have enabled breakthroughs in deep proteomics that will transform the cancer detection paradigm. Deep proteomic assays can now detect proteins 8-9 orders of magnitude lower in abundance than common plasma proteins. During this talk, Dr. Drake will detail the latest innovations and role of deep proteomics in early detection.
Spatial Showcase:
Astrin Biosciences
Astrin Biosciences is a cancer intelligence company built to push the boundaries of technology — accelerating early cancer detection and advancing cancer care.
